ClinicalTrials.Veeva

Menu

Comparison of Urinary Flow Study

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Enrolling

Conditions

Urinary Retention

Treatments

Device: Coloplast Micro Zone Luja Female Catheter
Device: Coloplast SpeediCath Female Catheter

Study type

Interventional

Funder types

Other

Identifiers

NCT06918067
IRB00128923

Details and patient eligibility

About

The purpose of this research study is to compare the urinary flow speed of two different female catheters in patients that use intermittent catheters to empty their bladder. The "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" will be compared to the "14 Fr Coloplast Micro Zone Luja Female Catheter." Participants will have one study visit that should take about an hour and will also receive a follow-up telephone call about one week after the visit.

Full description

The purpose of this crossover study is to compare the urinary flow speed of two different female catheters manufactured by Coloplast, the "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" vs "14 Fr Coloplast Micro Zone Luja Female Catheter" in patients that use intermittent catheters to empty their bladder. Patients will be randomly assigned to group A or group B using a closed-envelope randomization method. Group A will self catheter with Luja, backfill with sterile fluid volume equal to amount of urine collected, then self-catheter with SpeediCath. Group B will self catheter with SpeediCath, backfill with sterile fluid volume equal to amount of urine collected, then self-catheter with Luja. Outcomes will be measured with office uroflow device.

Enrollment

17 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female
  • Regular use of intermittent catheters to empty bladder, for at least 1 month before enrolment
  • Age 18 years or older
  • Required to adhere to the intervention procedure and not participate in any other clinical studies throughout the duration of this study

Exclusion criteria

  • Severe urinary tract abnormalities (e.g. excessive production of urinary mucus/sediments/debris)
  • Hypersensitive to the ingredients in the catheters being tested
  • Recent surgery, within 3 months
  • Currently being treated for urinary tract infection
  • Being pregnant or breastfeeding
  • Non-English speaking

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

17 participants in 2 patient groups

Luja / SpeediCath
Active Comparator group
Description:
Subjects randomized to this arm will perform intermittent self-catheterization using the Coloplast Micro Zone Luja Female Catheter first then have bladder backfilled with sterile fluid to the amount equal to the volume of first catheterization. Then the subject will perform intermittent self-catheterization using the Coloplast Female SpeediCath Urinary Catheter.
Treatment:
Device: Coloplast SpeediCath Female Catheter
Device: Coloplast Micro Zone Luja Female Catheter
SpeediCath / Luja
Active Comparator group
Description:
Subject randomized to this arm will perform intermittent self-catheterization using the Coloplast Female SpeediCath Urinary Catheter first then have bladder backfilled with sterile fluid to the amount equal to the volume of first catheterization. Then the subject will perform intermittent self-catheterization using the Coloplast Micro Zone Luja Female Catheter.
Treatment:
Device: Coloplast SpeediCath Female Catheter
Device: Coloplast Micro Zone Luja Female Catheter

Trial contacts and locations

1

Loading...

Central trial contact

Zahra Bahrani-Mostafvai, PhD; Michael Kennelly, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems